Drug Interactions between irinotecan and magnesium sulfate / potassium chloride / sodium sulfate
This report displays the potential drug interactions for the following 2 drugs:
- magnesium sulfate/potassium chloride/sodium sulfate
Interactions between your drugs
magnesium sulfate irinotecan
Applies to: magnesium sulfate / potassium chloride / sodium sulfate and irinotecan
If you are currently receiving treatment with irinotecan, let your doctor know before you use any kind of medication that has a laxative effect. Because irinotecan causes diarrhea in the majority of patients, it may not be advisable for you to use laxatives or bowel cleansing products, as this may increase the risk of dehydration and electrolyte abnormalities. In severe cases, dehydration and electrolyte abnormalities can lead to irregular heart rhythm, seizures, and kidney problems. Contact your doctor if you experience potential signs and symptoms of fluid and electrolyte depletion such as dizziness, lightheadedness, dry mouth, thirst, fatigue, weakness, muscle cramps, decreased urination, palpitation, and increased heart rate. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
sodium sulfate food
Applies to: magnesium sulfate / potassium chloride / sodium sulfate
Oral medications may not be properly absorbed when they are taken within one hour before starting sodium sulfate for bowel cleansing. Talk to your doctor or pharmacist to see if you should adjust the dosing schedule of your other medications before you begin bowel cleansing treatment. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.